Lawyer and accountant acquitted of insider trading
An accountant and lawyer accused of being involved in an insider trading ring have been acquitted by a court.
According to the Financial Services Authority (FSA), the case, which is the first of its kind the regulator has lost, was brought against Andrew King, an ex-finance director at biotech firm NeuTec Pharma and lawyer Michael McFall.
News reports claimed that Mr King provided the information relating to a proposed acquisition of NeuTec by Swiss firm Novartis.
Margaret Cole, director of enforcement and financial crime at the FSA, said: “Insider dealing cases are challenging to prove, but these were serious charges and we considered that the evidence provided a proper basis to put the case before a jury for them to decide.
“Criminal prosecutions are integral to the FSA’s long-term strategy of delivering credible deterrence and combating insider dealing.”
The judge discharged the jury from considering the case against Andrew Rimmington, a second lawyer, halfway through the hearing due to personal reasons.
Further figures provided by the FSA showed that the regulator is currently prosecuting 11 other people in relation to insider trading.
By Jim Ottewill
View other announcements from
Road to Recover Class Action Proceeds Grows More C...
New worldwide class action laws brought on by globalization and increased participation in opt-in litigation have led to increased complexity in class...
CompatibL and d-fine announce partnership
CompatibL, a recognised leading provider of risk management solutions, and d-fine, a European consulting firm handling complex technological and analy...
FundCount Wins Best Accounting Solution at Family ...
FundCount Wins Best Accounting Solution at Family Wealth Report AwardsMeets family office needs for a unified accounting, general ledger and reporting...